These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2156343)

  • 1. Effects of conjugated equine oestrogens with and without the addition of cyclical medrogestone on hot flushes, liver function, blood pressure and endocrinological indices.
    Sonnendecker EW; Polakow ES
    S Afr Med J; 1990 Mar; 77(6):281-5. PubMed ID: 2156343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of oestrogen-progestogen with clonidine in the climacteric syndrome.
    Sonnendecker EW; Polakow ES
    S Afr Med J; 1980 Nov; 58(19):753-6. PubMed ID: 6252641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogen-medrogestone regimen in hysterectomized postmenopausal women.
    Sonnendecker EW; Polakow ES; Benadé AJ; Simchowitz E
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 1):1128-34. PubMed ID: 2543223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
    Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding patterns in peri and postmenopausal women taking a continuous combined regimen of estradiol with norethisterone acetate or a conventional sequential regimen of conjugated equine estrogens with medrogestone.
    von Holst T; Lang E; Winkler U; Keil D
    Maturitas; 2002 Dec; 43(4):265-75. PubMed ID: 12468135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women.
    Schlegel W; Petersdorf LI; Junker R; Schulte H; Ebert C; Von Eckardstein A
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):643-51. PubMed ID: 10594527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological changes effected by estrogen-progestogen and clonidine treatment in climacteric women.
    Gerdes LC; Sonnendecker EW; Polakow ES
    Am J Obstet Gynecol; 1982 Jan; 142(1):98-104. PubMed ID: 6275706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.
    Cieraad D; Conradt C; Jesinger D; Bakowski M
    Arch Gynecol Obstet; 2006 May; 274(2):74-80. PubMed ID: 16491367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postmenopausal hormone substitution and its effects on the climacteric syndrome, body weight and blood pressure].
    Fritsch H; Fritsch W; Julius U; Rehak E; Wieczorek A; Hanefeld M
    Zentralbl Gynakol; 1997; 119(3):128-32. PubMed ID: 9173771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of conjugated estrogens with and without medrogestone: a prospective study.
    van der Mooren MJ; Leuven JA; Rolland R
    Maturitas; 1994 May; 19(1):33-42. PubMed ID: 7935030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of oestrogen-induced prolactin release by medroxyprogesterone acetate.
    Castelo-Branco C; Palacios S; Martinez de Osaba MJ; Balasch J; Fortuny A; Vanrell J
    Maturitas; 1994 Dec; 20(2-3):145-50. PubMed ID: 7715466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of medrogestone and conjugated oestrogens on serum lipid and lipoprotein concentrations.
    Teichmann AT; Wieland H; Cremer P; Hinney B; Kuhn W; Seidel D
    Maturitas; 1985 Nov; 7(4):343-50. PubMed ID: 3001482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of prolactin in the menopause.
    Metka M; Holzer G; Raimann H; Heytmanek G; Hartmann B; Kurz C
    Maturitas; 1994 Dec; 20(2-3):151-4. PubMed ID: 7715467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood flow in the internal carotid and middle cerebral arteries: effects of continuous oral conjugated equine estrogens administration with monthly progestogen supplementation on postmenopausal women.
    Penotti M; Sironi L; Castiglioni E; Miglierina L; Barletta L; Gabrielli L; Vignali M
    Menopause; 1999; 6(3):225-9. PubMed ID: 10486792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Continuous postmenopausal estrogen-progesterone therapy].
    Affinito P; Tommaselli GA; Morgera R; Rinaldi M; Di Mauro P; Nappi C
    Minerva Ginecol; 1993 Mar; 45(3):77-85. PubMed ID: 8392669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medroxyprogesterone and conjugated oestrogen are equivalent for hot flushes: a 1-year randomized double-blind trial following premenopausal ovariectomy.
    Prior JC; Nielsen JD; Hitchcock CL; Williams LA; Vigna YM; Dean CB
    Clin Sci (Lond); 2007 May; 112(10):517-25. PubMed ID: 17419685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of estrogen/medrogestone therapy on the apoprotein B-containing lipoproteins in postmenopausal women with type 2 diabetes mellitus under satisfactory and non-satisfactory glycemic control.
    Aguilar-Salinas CA; Arita Melzer O; Sauque Reyna L; Lopez A; Velasco Perez ML; Guillen LE; Gomez Perez FJ; Rull Rodrigo JA
    Isr Med Assoc J; 2001 Feb; 3(2):137-43. PubMed ID: 11344825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tibolone compared with sequential hormone replacement therapy on carbohydrate metabolism in postmenopausal women.
    Wiegratz I; Starflinger F; Tetzloff W; Leifels-Fischer B; Helmond FA; Dericks-Tan JS; Kuhl H
    Maturitas; 2002 Feb; 41(2):133-41. PubMed ID: 11836044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
    Chandeying V; Sangthawan M
    J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study.
    Harden CL; Herzog AG; Nikolov BG; Koppel BS; Christos PJ; Fowler K; Labar DR; Hauser WA
    Epilepsia; 2006 Sep; 47(9):1447-51. PubMed ID: 16981859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.